Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (NHPBP) Revenue (2016 - 2025)

Historic Revenue for National Healthcare Properties (NHPBP) over the last 13 years, with Q3 2025 value amounting to $86.0 million.

  • National Healthcare Properties' Revenue fell 327.64% to $86.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.5 million, marking a year-over-year decrease of 206.81%. This contributed to the annual value of $353.8 million for FY2024, which is 227.48% up from last year.
  • Per National Healthcare Properties' latest filing, its Revenue stood at $86.0 million for Q3 2025, which was down 327.64% from $85.3 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' Revenue registered a high of $88.9 million during Q3 2024, and its lowest value of $81.2 million during Q2 2021.
  • Moreover, its 5-year median value for Revenue was $85.7 million (2023), whereas its average is $85.4 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 1675.96% in 2021, then surged by 442.92% in 2023.
  • Over the past 5 years, National Healthcare Properties' Revenue (Quarter) stood at $82.8 million in 2021, then grew by 2.61% to $84.9 million in 2022, then increased by 2.2% to $86.8 million in 2023, then increased by 1.1% to $87.7 million in 2024, then fell by 1.95% to $86.0 million in 2025.
  • Its Revenue was $86.0 million in Q3 2025, compared to $85.3 million in Q2 2025 and $86.4 million in Q1 2025.